Research | OneLook Acronym Finder |
Serial Number | 86316014 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Matthew O. Brady |
Attorney Docket Number | BAN001 |
Law Office Assigned | L30 |
Employee Name | STRINGER, DANIEL S |
2014-06-20 | Application Filed |
2014-11-25 | Published for Opposition |
2017-08-01 | Location: INTENT TO USE SECTION |
2018-02-26 | Abandon |
2018-02-26 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Owner: | ACTAVIS HOLDCO US, INC. |
Address | 400 INTERPACE PARKWAY PARSIPPANY DE 07054 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2014-06-24 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-06-28 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2014-09-24 | 3 DOCK D:Assigned to Examiner |
EXAMINERS AMENDMENT -WRITTEN | 2014-10-01 | 4 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2014-10-01 | 5 GNEA F:First Action |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2014-10-01 | 6 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2014-10-01 | 7 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2014-10-01 | 8 CNSA P: |
ASSIGNED TO LIE | 2014-10-22 | 9 ALIE A:Allowance for Publication |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2014-10-22 | 10 PREV O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2014-11-05 | 11 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2014-11-25 | 12 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2014-11-25 | 13 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2015-01-20 | 14 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2015-07-20 | 15 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2015-07-20 | 16 EXT1 S: |
EXTENSION 1 GRANTED | 2015-07-20 | 17 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2015-07-22 | 18 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2016-01-20 | 19 EEXT I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2016-02-23 | 20 AITU A:Allowance for Publication |
EXTENSION 2 FILED | 2016-01-20 | 21 EXT2 S: |
EXTENSION 2 GRANTED | 2016-02-24 | 22 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-02-25 | 23 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2016-07-19 | 24 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2016-07-19 | 25 EXT3 S: |
EXTENSION 3 GRANTED | 2016-08-01 | 26 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-08-02 | 27 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2017-01-20 | 28 EEXT I:Incoming Correspondence |
EXTENSION 4 FILED | 2017-01-20 | 29 EXT4 S: |
EXTENSION 4 GRANTED | 2017-01-20 | 30 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-01-24 | 31 EXRA E:E-Mail |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2017-02-22 | 32 ASGN I:Incoming Correspondence |
TEAS EXTENSION RECEIVED | 2017-07-19 | 33 EEXT I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2017-08-01 | 34 AITU A:Allowance for Publication |
EXTENSION 5 FILED | 2017-07-19 | 35 EXT5 S: |
EXTENSION 5 GRANTED | 2017-08-01 | 36 EX5G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-08-02 | 37 EXRA E:E-Mail |
ABANDONMENT - NO USE STATEMENT FILED | 2018-02-26 | 38 ABN6 S: |
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2018-02-26 | 39 MAB6 O:Outgoing Correspondence |
UNDELIVERABLE MAIL - NO ACTION TAKEN | 2018-04-06 | 40 UNDN O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.